Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

UVA Health researchers develop new tool to advance genomics and disease research

UVA Health researchers have developed an important new tool to help scientists sort signal from noise as they probe the genetic causes of cancer and other diseases.

22 Nov 2022

Study challenges "good" cholesterol's predictive role for heart disease

A National Institutes of Health-supported study found that high-density lipoprotein (HDL) cholesterol, often called the "good cholesterol," may not be as effective as scientists once believed in uniformly predicting cardiovascular disease risk among adults of different racial and ethnic backgrounds.

21 Nov 2022

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

On November 17, 2022, the US Food and Drug Administration (FDA) approved a pathbreaking new drug called Tzield. This injectable formulation contains a combination of two drugs that could push back the onset of type 1 diabetes (T1D) in adults at stage 3 and children aged eight years or more at stage 2.

20 Nov 2022

Metabolomic study of genetic regulation of biochemical individuality

Researchers systematically investigated the genetic makeup of nearly 20,000 women and men in terms of >900 metabolites.

15 Nov 2022

Study shows link between morning physical activity and lowest risk of heart disease, stroke

Morning physical activity is associated with the lowest risk of heart disease and stroke, according to a study in more than 85,000 individuals published today in the European Journal of Preventive Cardiology, a journal of the ESC.

14 Nov 2022

New scientific statement highlights the impact of telehealth in cardiovascular disease management

Telehealth is a proven and valuable option for people with cardiovascular disease, however, there are limitations to its use in rural and under-resourced communities, according to a new scientific statement from the American Heart Association, published today in the Association's flagship peer-reviewed journal Circulation.

14 Nov 2022

Can monkeypox infection lead to myocarditis?

A recent study presents the first known case of myocarditis as a complication of monkeypox virus infection.

13 Nov 2022

Personalized 'precision' testing approach leads to efficient chest pain evaluations for heart disease risk

For people with stable chest pain, a personalized "precision" testing approach led to more efficient evaluations for heart disease risk and improved diagnosis and treatment of coronary artery disease when compared to usual care, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

New risk analysis strategy benefits chest pain patients compared to the usual testing approach

A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.

6 Nov 2022

Cannabis, cocaine, methamphetamine, and opiates increase risk of atrial fibrillation

A recent study published in the European Heart Journal reveals that using illicit drugs can increase atrial fibrillation risk.

6 Nov 2022

Study examines temporal effects of pre-existing CKD, other medical conditions on COVID-19 outcomes

Individuals with chronic kidney disease (CKD) are vulnerable to developing severe forms of COVID-19, and acute kidney injury is a common complication of COVID-19.

6 Nov 2022

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

A new study aimed to analyze the association between lifestyle risk factors, PRSs, and their interactions along with the risk of CVE within 90 days post-COVID-19 diagnosis.

31 Oct 2022

AI models improve the accuracy of diagnosing coronary artery disease

Several recent discoveries show that the accuracy of diagnosing coronary artery disease and predicting patient risk is improved with the help of artificial intelligence (AI) models developed by scientists in the Division of Artificial Intelligence in Medicine at Cedars-Sinai.

28 Oct 2022

Heart attack death rates took a sharp turn and increased during the pandemic, study shows

New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks rose significantly during pandemic surges, including the COVID-19 Omicron surges, overall reversing a heart-healthier pre-pandemic trend.

24 Oct 2022

Do hypertension, dyslipidemia, and new-onset diabetes mellitus play a part in post-COVID sequelae?

A new study evaluated the current research on incidences of hypertension, new-onset diabetes mellitus, and dyslipidemia as possible sequelae of coronavirus disease 2019 (COVID-19).

18 Oct 2022

High immune protein levels predict both heart failure and death

For years, cardiologists have zeroed in on a hormone called BNP as a gold standard to determine if patients with heart failure are at risk of severe illness or death. It's released by the heart in response to when the cardiac tissue stretches due to pressure.

17 Oct 2022

Illicit drugs associated with increased likelihood of developing atrial fibrillation

Methamphetamines, cocaine, opiates, and cannabis are associated with an increased likelihood of developing atrial fibrillation, according to an 11-year study in more than 23 million adults published today in European Heart Journal, a journal of the European Society of Cardiology.

17 Oct 2022

What is the impact of COVID-19 and organophosphates on cardiac health?

In a new study, researchers discussed the impacts of organophosphates (OP) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on cardiovascular (CVS) health.

17 Oct 2022

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main contributors to death and poor outcomes for critically ill COVID-19 patients.

12 Oct 2022

Insights into why midlife women gain weight

Weight gain is a common complaint of midlife women, with more than two-thirds of midlife US women being over the ideal weight threshold. Aging-related metabolic changes promote weight gain in both sexes, but women face additional challenges because of menopause.

12 Oct 2022

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

UVA Health researchers develop new tool to advance genomics and disease research

Study challenges "good" cholesterol's predictive role for heart disease

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

Metabolomic study of genetic regulation of biochemical individuality

Study shows link between morning physical activity and lowest risk of heart disease, stroke

New scientific statement highlights the impact of telehealth in cardiovascular disease management

Can monkeypox infection lead to myocarditis?

Personalized 'precision' testing approach leads to efficient chest pain evaluations for heart disease risk

New risk analysis strategy benefits chest pain patients compared to the usual testing approach

Cannabis, cocaine, methamphetamine, and opiates increase risk of atrial fibrillation

Study examines temporal effects of pre-existing CKD, other medical conditions on COVID-19 outcomes

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

AI models improve the accuracy of diagnosing coronary artery disease

Heart attack death rates took a sharp turn and increased during the pandemic, study shows

Do hypertension, dyslipidemia, and new-onset diabetes mellitus play a part in post-COVID sequelae?

High immune protein levels predict both heart failure and death

Illicit drugs associated with increased likelihood of developing atrial fibrillation

What is the impact of COVID-19 and organophosphates on cardiac health?

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

Insights into why midlife women gain weight

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in